Additional MKD 100 million approved for cystic fibrosis medication Kaftrio


The Ministry of Health said Wednesday that an additional MKD 100 million have been approved for the procurement of Kaftrio (Trikafta) and Kalydeco, the prescription medicine used for the treatment of cystic fibrosis.

The Clinic of Children’s Diseases, the press release reads, received an approval from the Ministry of Health, the Health Insurance Fund and Public Procurement Bureau for immediate procurement though direct negotiations with the authorized distributor of Vertex Pharmaceuticals.

The Clinic for Children’s diseases, which is supposed to procure the medicine, said that an agreement was signed between directors of the Clinic and Alkaloid KONS on November 21, and the medicine is supposed to be delivered in the first half of December of this year.

“The current twelve patients, who already receive the medicine, will be receiving 102 therapy regimens for another two months (until April 2024), and the medicine will also be available for additional patients who meet the criteria for Kaftrio in combination with Kalydeco,” the Clinic announced.



Previous articleKovachevski at NATO regional summit: EU membership is our goal, we have no other alternative
Next articleTaravari: We had meetings with Ahmeti and Kovachevski, but for now we are against the option of going to the elections together with single electoral list


Please enter your comment!
Please enter your name here